CH626057A5 - - Google Patents

Download PDF

Info

Publication number
CH626057A5
CH626057A5 CH334576A CH334576A CH626057A5 CH 626057 A5 CH626057 A5 CH 626057A5 CH 334576 A CH334576 A CH 334576A CH 334576 A CH334576 A CH 334576A CH 626057 A5 CH626057 A5 CH 626057A5
Authority
CH
Switzerland
Prior art keywords
oxime
compounds
salts
aminoethyl
pharmaceutically acceptable
Prior art date
Application number
CH334576A
Other languages
German (de)
English (en)
Inventor
Hendricus Bernardus Anto Welle
Volkert Claassen
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of CH626057A5 publication Critical patent/CH626057A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32Oximes
    • C07C251/50Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH334576A 1975-03-20 1976-03-17 CH626057A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.

Publications (1)

Publication Number Publication Date
CH626057A5 true CH626057A5 (en:Method) 1981-10-30

Family

ID=19823424

Family Applications (4)

Application Number Title Priority Date Filing Date
CH334576A CH626057A5 (en:Method) 1975-03-20 1976-03-17
CH154181A CH629761A5 (de) 1975-03-20 1981-03-06 Verfahren zur herstellung neuer oximaetherverbindungen.
CH153981A CH629184A5 (de) 1975-03-20 1981-03-06 Verfahren zur herstellung neuer oximaetherverbindungen.
CH154081A CH629477A5 (de) 1975-03-20 1981-03-06 Verfahren zur herstellung neuer oximaetherverbindungen.

Family Applications After (3)

Application Number Title Priority Date Filing Date
CH154181A CH629761A5 (de) 1975-03-20 1981-03-06 Verfahren zur herstellung neuer oximaetherverbindungen.
CH153981A CH629184A5 (de) 1975-03-20 1981-03-06 Verfahren zur herstellung neuer oximaetherverbindungen.
CH154081A CH629477A5 (de) 1975-03-20 1981-03-06 Verfahren zur herstellung neuer oximaetherverbindungen.

Country Status (27)

Country Link
US (1) US4085225A (en:Method)
JP (1) JPS6026776B2 (en:Method)
AR (2) AR211011A1 (en:Method)
AT (1) AT340895B (en:Method)
AU (1) AU505358B2 (en:Method)
BE (1) BE839744A (en:Method)
CA (1) CA1076142A (en:Method)
CH (4) CH626057A5 (en:Method)
DD (1) DD128332A5 (en:Method)
DE (1) DE2610886A1 (en:Method)
DK (1) DK144942C (en:Method)
ES (1) ES446192A1 (en:Method)
FI (1) FI61875C (en:Method)
FR (1) FR2304336A1 (en:Method)
GB (1) GB1535226A (en:Method)
GR (1) GR60052B (en:Method)
HU (1) HU171030B (en:Method)
IE (1) IE43768B1 (en:Method)
IL (1) IL49238A (en:Method)
IT (1) IT1063064B (en:Method)
MX (1) MX9203723A (en:Method)
NL (1) NL7503310A (en:Method)
PL (3) PL100614B1 (en:Method)
SE (1) SE410312B (en:Method)
SU (3) SU635867A3 (en:Method)
YU (1) YU39345B (en:Method)
ZA (1) ZA761434B (en:Method)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1110460B (it) * 1977-03-02 1985-12-23 Ciba Geigy Ag Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
ATE192042T1 (de) * 1995-08-16 2000-05-15 Lilly Co Eli Potenzierung von serotonin-wirkstoffresponz
IN182588B (en:Method) 1998-05-12 1999-05-08 Sun Pharmaceutical Ind Ltd
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
IN186677B (en:Method) 1999-11-12 2001-10-20 Sun Pharmaceutical Ind Ltd
US20080021085A1 (en) * 2000-04-13 2008-01-24 Mayo Foundation For Medical Education And Research Method of reducing abeta42 and treating diseases
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
US7256191B2 (en) * 2000-04-24 2007-08-14 Aryx Therapeutics Materials and methods for the treatment of depression
JP2003531169A (ja) 2000-04-24 2003-10-21 アリックス セラピューティクス うつ病治療のための材料と方法
CN1606554B (zh) * 2001-10-12 2013-03-20 阿泽范药品公司 β-内酰胺后叶加压素V1a拮抗剂
KR20040088519A (ko) 2002-02-22 2004-10-16 뉴 리버 파마슈티칼스, 인크. 활성 제제 전달 시스템 및 활성 제제의 보호 및 투여 방법
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
EP1651195A4 (en) * 2003-07-11 2007-10-03 Myriad Genetics Inc PHARMACEUTICAL PROCESSES, DOSIERSCHEMATA AND DOSAGE FORMS FOR THE TREATMENT OF ALZHEIMER DISEASE
RU2320369C2 (ru) 2003-09-12 2008-03-27 Пфайзер Инк. Комбинации, содержащие альфа-2-дельта лиганды и ингибиторы обратного захвата серотонина/норадреналина
BRPI0416989A (pt) * 2003-11-26 2007-02-06 Pfizer Prod Inc derivados aminopirazole como inibidores gsk-3
WO2005060968A1 (en) 2003-12-11 2005-07-07 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
EP1737473A4 (en) * 2004-04-19 2009-08-26 Noven Therapeutics Llc COMBINATIONS OF LITHIUM AND USES THEREOF
KR20070004036A (ko) * 2004-04-29 2007-01-05 키스톤 리테이닝 월 시스템스, 아이엔씨 벽, 옹벽 및 그 외 유사한 것을 위한 베니어
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
EP1868434A4 (en) 2005-03-22 2011-10-26 Azevan Pharmaceuticals Inc BETA-LACTAMYL ALKANIC ACIDS FOR THE TREATMENT OF PREMIERSTRUELLEN FAULTS
WO2006116151A1 (en) 2005-04-22 2006-11-02 Wyeth Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
MX2007012883A (es) 2005-04-22 2007-12-10 Wyeth Corp Derivados de dihidrobenzofurano y usos de los mismos.
AR055054A1 (es) * 2005-04-22 2007-08-01 Wyeth Corp Cristales formados de clorhidrato de (((2r)-7-(2,6-diclorofenil)-5-fluoro-2,3- dihidro-1-benzofurano-2-il) metil ) amina
GT200600165A (es) * 2005-04-22 2007-03-14 Derivados dihidrobenzofuranos y usos de los mismos
NZ565683A (en) * 2005-07-08 2011-04-29 Braincells Inc Methods for identifying agents and conditions that modulate neurogenesis in human neural cells
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
WO2007011878A2 (en) * 2005-07-19 2007-01-25 Azevan Pharmaceuticals, Inc. Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
WO2007014124A2 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
TW200806300A (en) * 2006-03-24 2008-02-01 Wyeth Corp New therapeutic combinations for the treatment of depression
JP4615470B2 (ja) * 2006-03-29 2011-01-19 卓郎 簑和田 大脳の認知力を用いた疾患治療・予防の方法および医薬
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
CA2651862A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
BRPI0716604A2 (pt) 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
WO2008034032A2 (en) * 2006-09-14 2008-03-20 Azevan Pharmaceuticals, Inc. Beta-lactam cannabinoid receptor modulators
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080167363A1 (en) * 2006-12-28 2008-07-10 Braincells, Inc Modulation of Neurogenesis By Melatoninergic Agents
CA2675132A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
US20110034565A1 (en) 2008-04-18 2011-02-10 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
US20100092479A1 (en) * 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
SMT201900392T1 (it) 2009-10-23 2019-09-09 Janssen Pharmaceutica Nv Ottaidropirrolo[3,4-c]pirroli disostituiti come modulatori del recettore di orexina
JP5815552B2 (ja) 2009-12-08 2015-11-17 ケース ウェスタン リザーブ ユニバーシティCase Westernreserve University 眼疾患を治療する化合物および方法
PL3351104T3 (pl) 2010-07-01 2021-06-14 Azevan Pharmaceuticals, Inc. Związki do stosowania w leczeniu okresowych zaburzeń wybuchowych
JP2014508187A (ja) 2011-03-17 2014-04-03 ルピン・リミテッド 選択的セロトニン再取り込み阻害薬の放出制御医薬組成物
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
IN2013MU01290A (en:Method) 2013-04-03 2015-04-10 Zcl Chemicals Ltd
JP6723930B2 (ja) 2014-02-07 2020-07-15 エムティーエー タモガトット クタトクソポルトク イロダジャ シグマ−1−受容体アゴニスト化合物の新規使用
BR112016022575A2 (pt) 2014-03-28 2017-08-15 Azevan Pharmaceuticals Inc Composições e métodos para o tratamento de doenças neurodegenerativas
KR20230116948A (ko) * 2016-03-10 2023-08-04 얀센 파마슈티카 엔.브이. 오렉신-2 수용체 길항제를 사용한 우울증의 치료 방법
EP3544420B8 (en) 2016-11-24 2022-11-23 Sigmadrugs Kutató Korlátolt Felelösségü Társaság Use of compositions for organ/tissue preservation
CN111295373B (zh) 2017-09-15 2024-12-10 阿泽凡药物公司 用于治疗脑损伤的组合物和方法
KR20220049526A (ko) 2019-07-19 2022-04-21 바이오엑셀 테라퓨틱스 인코포레이티드 비-진정성 덱스메데토미딘 치료 양생법
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes

Also Published As

Publication number Publication date
AR211153A1 (es) 1977-10-31
US4085225A (en) 1978-04-18
DK144942C (da) 1982-12-06
YU71476A (en) 1982-10-31
SE410312B (sv) 1979-10-08
DK115976A (da) 1976-09-21
HU171030B (hu) 1977-10-28
CA1076142A (en) 1980-04-22
CH629761A5 (de) 1982-05-14
FI61875B (fi) 1982-06-30
SU620206A3 (ru) 1978-08-15
AT340895B (de) 1978-01-10
FR2304336B1 (en:Method) 1979-09-28
AU1214776A (en) 1977-09-22
PL100614B1 (pl) 1978-10-31
JPS6026776B2 (ja) 1985-06-25
FR2304336A1 (fr) 1976-10-15
IL49238A (en) 1978-08-31
SE7603341L (sv) 1976-09-21
PL100052B1 (pl) 1978-08-31
ES446192A1 (es) 1977-10-01
YU39345B (en) 1984-10-31
IL49238A0 (en) 1976-05-31
AR211011A1 (es) 1977-10-14
IE43768B1 (en) 1981-05-20
AU505358B2 (en) 1979-11-15
SU635867A3 (ru) 1978-11-30
GR60052B (en) 1978-04-04
SU645559A3 (ru) 1979-01-30
GB1535226A (en) 1978-12-13
ATA195476A (de) 1977-05-15
IE43768L (en) 1976-09-20
CH629184A5 (de) 1982-04-15
DE2610886C2 (en:Method) 1987-09-24
BE839744A (fr) 1976-09-20
JPS51125345A (en) 1976-11-01
DK144942B (da) 1982-07-12
CH629477A5 (de) 1982-04-30
IT1063064B (it) 1985-02-11
DE2610886A1 (de) 1976-10-07
PL101951B1 (pl) 1979-02-28
MX9203723A (es) 1992-07-01
FI61875C (fi) 1982-10-11
ZA761434B (en) 1977-10-26
DD128332A5 (de) 1977-11-09
FI760699A7 (en:Method) 1976-09-21
NL7503310A (nl) 1976-09-22

Similar Documents

Publication Publication Date Title
CH626057A5 (en:Method)
CH616676A5 (en:Method)
CH615677A5 (en:Method)
DE2305092C2 (en:Method)
CH622507A5 (en) Process for the preparation of 1,4-dihydropyridines
CH626062A5 (en:Method)
CH622501A5 (en:Method)
DE2610679C2 (de) Sulfinylgruppenhaltige Oximätherderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Mittel
CH626056A5 (en:Method)
DE2353160C2 (de) 5-Phenyl-2,3-dihydro-1H-1,4-benzodiazepine, ihre Säureadditionssalze und diese Verbindungen enthaltende Arzneimittel
DE2034588C3 (de) 6,7-Dimethoxy-4-benzylisochinoline, Verfahren zu ihrer Herstellung und Arzneimittel
DD148633A5 (de) Verfahren zur herstellung von hexahydro-1,4-oxazepinen
DE2244737B2 (de) H-o-ChlorphenyD-2-tert-butylaminoäthanol, Verfahren zu dessen Herstellung und Arzneimittel auf dessen Basis
DE2421549A1 (de) Naphthalinderivate, verfahren zu ihrer herstellung und arzneimittel
DE2615129A1 (de) Tripeptide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE69621706T2 (de) Verwendung von Piperazinverbindungen als narkotische Antagonisten
DE2003353B2 (de) Phenylisopropylaminoäthanol-Derivate, deren Herstellungsverfahren und Arzneimittel auf deren Basis
DE2538593C3 (de) m-Trifluormethylthio-phenäthylaminderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2810482A1 (de) 1-phenyl-2- eckige klammer auf (n-alkyl)-amino eckige klammer zu -propan-1,3-diole, solche enthaltende arzneimittel und verfahren zur herstellung derselben
AT278785B (de) Verfahren zur Herstellung von neuen Piperidinderivaten und ihren Salzen
DE2022790C3 (de) 10-Methyl-5-[ (4-Methylpiperazino)-acetyl J-5,10dihydro-llH-dibenzo [b,e ] [1,4 ] diazepin-11-on, ein Verfahren zu dessen Herstellung sowie dieses enthaltende Arzneimittel
DE1951614B2 (de) Substituierte Benzylalkohol, deren physiologisch verträgliche Salze, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2518514A1 (de) 1,3,4-trimethyl-2-(3,4,5-trimethoxybenzyl)-1,2,5,6-tetrahydropyridin, verfahren zu seiner herstellung sowie es enthaltende arzneimittel
CH454147A (de) Verfahren zur Herstellung eines neuen Isoxazolderivates
DE2538593B2 (de) M-trifluormethylthio-phenaethylaminderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Legal Events

Date Code Title Description
PL Patent ceased
SPCF Supplementary protection certificate filed

Free format text: IKS 44603/830713, 960221

SPCG Supplementary protection certificate granted

Free format text: IKS 44603/830713, 960221, EXPIRES:19980713